Guidance On Nucleic Acid-Based IVDs Recommends Analytical, Clinical Studies
This article was originally published in The Gray Sheet
Executive Summary
An FDA final guidance released Aug. 27 on highly multiplexed microbiological in vitro nucleic-acid based diagnostics recommends studies on both the analytical and clinical performance of the devices.